AI in drug discovery

News

Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.

News

Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.

News

AI startup Bioptimus takes its funding above $76m as it prepares for the launch of a universal foundation model for pathology later this year.

News

Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.

News

Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.

News

Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug.